1,2,4,5-Tetraoxane Conjugates as a Novel Ferrous Iron-Activatable Platform for Targeted Tumor Drug Delivery

Elevated intracellular labile ferrous iron is a hallmark of many cancers and can activate endoperoxide-containing molecules through Fenton chemistry. We developed a ferrous iron-activatable drug conjugate (FeADC) platform based on a 1,2,4,5-tetraoxane scaffold for tumor-selective drug delivery. Doxorubicin-loaded tetraoxane conjugates release their payload in the presence of Fe(II) via tandem endoperoxide reduction and retro-Michael elimination. These FeADCs exhibited potent antiproliferative activity across cancer cell lines with dysregulated iron metabolism while displaying markedly improved selectivity over doxorubicin in nontumorigenic cells. Fluorescence microscopy confirmed the efficient intracellular release of doxorubicin in HCT116 colorectal cancer cells. Moreover, in a colorectal cancer xenograft model, the tetraoxane conjugate achieved tumor growth inhibition comparable to that of doxorubicin administered at an equivalent dose. Collectively, these findings establish the 1,2,4,5-tetraoxane scaffold as a promising ferrous iron-responsive platform for tumor-activated prodrugs, enabling targeted drug release and potentially improving the therapeutic index of anticancer agents.

Authors

Institutions

Publication Details

Journal
ACS Pharmacology & Translational Science
Published
2026-11-18
DOI
https://doi.org/10.1021/acsptsci.6c00516
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

1,2,4,5-Tetraoxane Conjugates as a Novel Ferrous Iron-Activatable Platform for Targeted Tumor Drug Delivery

Maria Manuela Gaspar, Andreia Bento‐Silva, Cláudia Mourato, Vanda Marques et al.
1 links
ACS Pharmacology & Translational Science
Nanoparticle-Based Drug Delivery
article

1,2,4,5-Tetraoxane Conjugates as a Novel Ferrous Iron-Activatable Platform for Targeted Tumor Drug Delivery

Maria Manuela Gaspar, Andreia Bento‐Silva, Cláudia Mourato, Vanda Marques, Adam R. Renslo, Rui Moreira, Francisca Lopes, Catarina I. G. Pinto, Ricardo Lopes, Diogo Silva, Cecília M. P. Rodrigues
article en

Abstract

Elevated intracellular labile ferrous iron is a hallmark of many cancers and can activate endoperoxide-containing molecules through Fenton chemistry. We developed a ferrous iron-activatable drug conjugate (FeADC) platform based on a 1,2,4,5-tetraoxane scaffold for tumor-selective drug delivery. Doxorubicin-loaded tetraoxane conjugates release their payload in the presence of Fe(II) via tandem endoperoxide reduction and retro-Michael elimination. These FeADCs exhibited potent antiproliferative activity across cancer cell lines with dysregulated iron metabolism while displaying markedly improved selectivity over doxorubicin in nontumorigenic cells. Fluorescence microscopy confirmed the efficient intracellular release of doxorubicin in HCT116 colorectal cancer cells. Moreover, in a colorectal cancer xenograft model, the tetraoxane conjugate achieved tumor growth inhibition comparable to that of doxorubicin administered at an equivalent dose. Collectively, these findings establish the 1,2,4,5-tetraoxane scaffold as a promising ferrous iron-responsive platform for tumor-activated prodrugs, enabling targeted drug release and potentially improving the therapeutic index of anticancer agents.

ACS Pharmacology & Translational Science
University of Lisbon (PT), University of California, San Francisco (US)
“la Caixa” Foundation, Fundação para a Ciência e a Tecnologia, European Regional Development Fund, NHLBI Division of Intramural Research
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon